Profile
Cynthia L.
Anderson formerly worked at Alnylam Pharmaceuticals, Inc., as Chief Accounting Officer from 2019 to 2023 and Vistagen Therapeutics, Inc., as Chief Financial Officer from 2023 to 2025.
Ms. Anderson received her undergraduate degree from the University of Connecticut and graduate degree from The University of Texas at Dallas.
Former positions of Cynthia Anderson
| Companies | Position | End |
|---|---|---|
| VISTAGEN THERAPEUTICS, INC. | Director of Finance/CFO | 15/09/2025 |
| ALNYLAM PHARMACEUTICALS, INC. | Comptroller/Controller/Auditor | 01/01/2023 |
Training of Cynthia Anderson
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
Alnylam Pharmaceuticals, Inc.
Alnylam Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics based on RNA interference | Health Technology |
University of Connecticut
University of Connecticut Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Texas at Dallas
The University of Texas at Dallas Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
VistaGen Therapeutics, Inc.
VistaGen Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops central nervous system therapies | Health Technology |
- Stock Market
- Insiders
- Cynthia Anderson
















